Dr. Kehas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Chambers Dr
# Elliot
Hooksett, NH 03106Phone+1 603-624-8652Fax+1 603-624-6609
Education & Training
Concord Hospital/New Hampshire-Dartmouth Family MedicineResidency, Family Medicine, 2003 - 2006
Tufts University School of MedicineClass of 2003
Certifications & Licensure
NH State Medical License 2006 - 2026- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Most Compassionate Doctor American Registry
Publications & Presentations
PubMed
- 101 citationsHuman ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISPeter T. Masiakos, David T. MacLaughlin, Shyamala Maheswaran, José A. Teixeira, Arlan F. Fuller
Clinical Cancer Research. 1999-11-01 - 37 citationsTranscriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cellsJosé A. Teixeira, David J. Kehas, Reem Antun, Patricia K. Donahoe
Proceedings of the National Academy of Sciences of the United States of America. 1999-11-23 - 57 citationsDiagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell TumorsAndrew H. Lane, Mary M. Lee, Arlan F. Fuller, David J. Kehas, Patricia K. Donahoe
Gynecologic Oncology. 1999-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
